Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,705
-$3,515 QoQ
Shares Held
33
-45.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Evelyn Partners Investment Management LLP holds $72,886,643 across 7 Diagnostics & Research names. GRAL ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,140 | $53,645,584 | |
| 2 | DHR |
Danaher Corp /De/
|
99,678 | $18,898,948 | |
| 3 | WAT |
Waters Corp /De/
|
856 | $254,916 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
34 | $42,880 | |
| 5 | ILMN |
Illumina, Inc.
|
291 | $35,868 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
12 | $6,742 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
33 | $1,705 |
All Filings in GRAL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,705 | 33 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,220 | 61 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,139 | 70 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,599 | 70 | Shares | Sole | 2025-11-26 | |
| 2025-03-31 | $2,094 | 82 | Shares | Sole | 2025-12-08 | |
| 2024-12-31 | $1,677 | 94 | Shares | Sole | 2025-12-11 | |
| No filing history on record for this holder in this stock. | ||||||